Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease

Detalhes bibliográficos
Autor(a) principal: Mata, Mario de la
Data de Publicação: 2017
Outros Autores: Cotán, David, Oropesa-Ávila, Manuel, Villanueva-Paz, Marina, Lavera, Isabel de, Álvarez-Córdoba, Mónica, Luzón-Hidalgo, Raquel, Suárez-Rivero, Juan M., Tiscornia, Gustavo, Sánchez-Alcázar, José A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.1/9015
Resumo: Background Gaucher disease (GD) is caused by mutations in the GBA1 gene which encodes lysosomal β-glucocerebrosidase (GCase). In GD, partial or complete loss of GCase activity causes the accumulation of the glycolipids glucosylceramide (GlcCer) and glucosylsphingosine in the lysosomes of macrophages. In this manuscript, we investigated the effects of glycolipids accumulation on lysosomal and mitochondrial function, inflammasome activation and efferocytosis capacity in a THP-1 macrophage model of Gaucher disease. In addition, the beneficial effects of coenzyme Q10 (CoQ) supplementation on cellular alterations were evaluated. Chemically-induced Gaucher macrophages were developed by differentiateing THP-1 monocytes to macrophages by treatment with phorbol 12-myristate 13-acetate (PMA) and then inhibiting intracellular GCase with conduritol B-epoxide (CBE), a specific irreversible inhibitor of GCase activity, and supplementing the medium with exogenous GlcCer. This cell model accumulated up to 16-fold more GlcCer compared with control THP-1 cells. Results Chemically-induced Gaucher macrophages showed impaired autophagy flux associated with mitochondrial dysfunction and increased oxidative stress, inflammasome activation and impaired efferocytosis. All abnormalities were partially restored by supplementation with CoQ. Conclusion These data suggest that targeting mitochondria function and oxidative stress by CoQ can ameliorate the pathological phenotype of Gaucher cells. Chemically-induced Gaucher macrophages provide cellular models that can be used to investigate disease pathogenesis and explore new therapeutics for GD.
id RCAP_0889abd6ab0ba95e0bb91796beaebc29
oai_identifier_str oai:sapientia.ualg.pt:10400.1/9015
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher diseaseGaucher diseaseInflammasomeEfferocytosisOxidative stressMitochondriaCoenzyme Q10Background Gaucher disease (GD) is caused by mutations in the GBA1 gene which encodes lysosomal β-glucocerebrosidase (GCase). In GD, partial or complete loss of GCase activity causes the accumulation of the glycolipids glucosylceramide (GlcCer) and glucosylsphingosine in the lysosomes of macrophages. In this manuscript, we investigated the effects of glycolipids accumulation on lysosomal and mitochondrial function, inflammasome activation and efferocytosis capacity in a THP-1 macrophage model of Gaucher disease. In addition, the beneficial effects of coenzyme Q10 (CoQ) supplementation on cellular alterations were evaluated. Chemically-induced Gaucher macrophages were developed by differentiateing THP-1 monocytes to macrophages by treatment with phorbol 12-myristate 13-acetate (PMA) and then inhibiting intracellular GCase with conduritol B-epoxide (CBE), a specific irreversible inhibitor of GCase activity, and supplementing the medium with exogenous GlcCer. This cell model accumulated up to 16-fold more GlcCer compared with control THP-1 cells. Results Chemically-induced Gaucher macrophages showed impaired autophagy flux associated with mitochondrial dysfunction and increased oxidative stress, inflammasome activation and impaired efferocytosis. All abnormalities were partially restored by supplementation with CoQ. Conclusion These data suggest that targeting mitochondria function and oxidative stress by CoQ can ameliorate the pathological phenotype of Gaucher cells. Chemically-induced Gaucher macrophages provide cellular models that can be used to investigate disease pathogenesis and explore new therapeutics for GD.BioMed CentralSapientiaMata, Mario de laCotán, DavidOropesa-Ávila, ManuelVillanueva-Paz, MarinaLavera, Isabel deÁlvarez-Córdoba, MónicaLuzón-Hidalgo, RaquelSuárez-Rivero, Juan M.Tiscornia, GustavoSánchez-Alcázar, José A.2017-03-07T10:01:15Z2017-02-062017-02-06T17:04:06Z2017-02-06T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.1/9015engOrphanet Journal of Rare Diseases. 2017 Feb 06;12(1):23http://dx.doi.org/10.1186/s13023-017-0574-8info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-24T10:20:21Zoai:sapientia.ualg.pt:10400.1/9015Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:01:01.338916Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
title Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
spellingShingle Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
Mata, Mario de la
Gaucher disease
Inflammasome
Efferocytosis
Oxidative stress
Mitochondria
Coenzyme Q10
title_short Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
title_full Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
title_fullStr Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
title_full_unstemmed Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
title_sort Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
author Mata, Mario de la
author_facet Mata, Mario de la
Cotán, David
Oropesa-Ávila, Manuel
Villanueva-Paz, Marina
Lavera, Isabel de
Álvarez-Córdoba, Mónica
Luzón-Hidalgo, Raquel
Suárez-Rivero, Juan M.
Tiscornia, Gustavo
Sánchez-Alcázar, José A.
author_role author
author2 Cotán, David
Oropesa-Ávila, Manuel
Villanueva-Paz, Marina
Lavera, Isabel de
Álvarez-Córdoba, Mónica
Luzón-Hidalgo, Raquel
Suárez-Rivero, Juan M.
Tiscornia, Gustavo
Sánchez-Alcázar, José A.
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Sapientia
dc.contributor.author.fl_str_mv Mata, Mario de la
Cotán, David
Oropesa-Ávila, Manuel
Villanueva-Paz, Marina
Lavera, Isabel de
Álvarez-Córdoba, Mónica
Luzón-Hidalgo, Raquel
Suárez-Rivero, Juan M.
Tiscornia, Gustavo
Sánchez-Alcázar, José A.
dc.subject.por.fl_str_mv Gaucher disease
Inflammasome
Efferocytosis
Oxidative stress
Mitochondria
Coenzyme Q10
topic Gaucher disease
Inflammasome
Efferocytosis
Oxidative stress
Mitochondria
Coenzyme Q10
description Background Gaucher disease (GD) is caused by mutations in the GBA1 gene which encodes lysosomal β-glucocerebrosidase (GCase). In GD, partial or complete loss of GCase activity causes the accumulation of the glycolipids glucosylceramide (GlcCer) and glucosylsphingosine in the lysosomes of macrophages. In this manuscript, we investigated the effects of glycolipids accumulation on lysosomal and mitochondrial function, inflammasome activation and efferocytosis capacity in a THP-1 macrophage model of Gaucher disease. In addition, the beneficial effects of coenzyme Q10 (CoQ) supplementation on cellular alterations were evaluated. Chemically-induced Gaucher macrophages were developed by differentiateing THP-1 monocytes to macrophages by treatment with phorbol 12-myristate 13-acetate (PMA) and then inhibiting intracellular GCase with conduritol B-epoxide (CBE), a specific irreversible inhibitor of GCase activity, and supplementing the medium with exogenous GlcCer. This cell model accumulated up to 16-fold more GlcCer compared with control THP-1 cells. Results Chemically-induced Gaucher macrophages showed impaired autophagy flux associated with mitochondrial dysfunction and increased oxidative stress, inflammasome activation and impaired efferocytosis. All abnormalities were partially restored by supplementation with CoQ. Conclusion These data suggest that targeting mitochondria function and oxidative stress by CoQ can ameliorate the pathological phenotype of Gaucher cells. Chemically-induced Gaucher macrophages provide cellular models that can be used to investigate disease pathogenesis and explore new therapeutics for GD.
publishDate 2017
dc.date.none.fl_str_mv 2017-03-07T10:01:15Z
2017-02-06
2017-02-06T17:04:06Z
2017-02-06T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.1/9015
url http://hdl.handle.net/10400.1/9015
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Orphanet Journal of Rare Diseases. 2017 Feb 06;12(1):23
http://dx.doi.org/10.1186/s13023-017-0574-8
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133237595865088